Literature DB >> 16200547

Application of powder X-ray diffraction in studying the compaction behavior of bulk pharmaceutical powders.

Rebanta Bandyopadhyay1, Jon Selbo, Gregory E Amidon, Michael Hawley.   

Abstract

This study investigates the effects of crystal lattice deformation on the powder X-ray diffraction (PXRD) patterns of compressed polycrystalline specimen (compacts/tablets) made from molecular, crystalline powders. The displacement of molecules and the corresponding adjustment of interplanar distances (d-spacings) between diffracting planes of PNU-288034 and PNU-177553, which have crystal habits with a high aspect ratio favoring preferred orientation during tableting, are demonstrated by shifts in the diffracted peak positions. The direction of shift in diffracted peak positions suggests a reduction of interplanar d-spacing in the crystals of PNU-288034 and PNU-177553 following compaction. There is also a general reduction of peak intensities following compression at the different compressive loads. The lattice strain representing the reduction in d-spacing is proportional to the original d-spacing of the uncompressed sample suggesting that, as with systems that obey a simple Hooke's law relationship, the further apart the planes of atoms/molecules within the lattice are, the easier it is for them to approach each other under compressive stresses. For a third model compound comprising more equant-shaped crystals of PNU-141659, the shift in diffracted peak positions are consistent with an expansion of lattice spacing after compression. This apparent anomaly is supported by the PXRD studies of the bulk powder consisting of fractured crystals where also, the shift in peak position suggests expansion of the lattice planes. Thus the crystals of PNU-141659 may be fracturing under the compressive loads used to produce the compacts. Additional studies are underway to relate the PXRD observations with the bulk tableting properties of these model compounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200547     DOI: 10.1002/jps.20415

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Heterogeneous activation of persulfate by reduced graphene oxide-elemental silver/magnetite nanohybrids for the oxidative degradation of pharmaceuticals and endocrine disrupting compounds in water.

Authors:  Chang Min Park; Jiyong Heo; Dengjun Wang; Chunming Su; Yeomin Yoon
Journal:  Appl Catal B       Date:  2018-06-05       Impact factor: 19.503

2.  Evaluation of the colloidal stability and adsorption performance of reduced graphene oxide-elemental silver/magnetite nanohybrids for selected toxic heavy metals in aqueous solutions.

Authors:  Chang Min Park; Dengjun Wang; Jonghun Han; Jiyong Heo; Chunming Su
Journal:  Appl Surf Sci       Date:  2019       Impact factor: 6.707

3.  Dissolution enhancement of chlorzoxazone using cogrinding technique.

Authors:  Mihir K Raval; Jaydeep M Patel; Rajesh K Parikh; Navin R Sheth
Journal:  Int J Pharm Investig       Date:  2015 Oct-Dec

4.  Characterization of Boswellia rivae Engl Resin as a Potential Use for Pharmaceutical Excipient.

Authors:  Fanta Gashe; Desta Assefa; Shibiru Tesema; Gemechu Zeleke; Ramanjireddy Tatiparthi; Dereje Kebebe; Sultan Suleman
Journal:  Biomed Res Int       Date:  2022-08-08       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.